Thurston Springer Miller Herd & Titak’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Buy
3,012
+396
+15% +$136K 0.4% 65
2026
Q1
$921K Sell
2,616
-1,460
-36% -$520K 0.38% 62
2025
Q4
$1.33M Buy
4,076
+3,354
+465% +$1.06M 0.47% 41
2025
Q3
$204K Sell
722
-10,471
-94% -$3.04M 0.4% 70
2025
Q2
$3.13M Buy
11,193
+1,468
+15% +$416K 0.4% 62
2025
Q1
$3.03M Buy
9,725
+2,140
+28% +$632K 0.51% 51
2024
Q4
$1.98M Buy
7,585
+2,147
+39% +$637K 0.4% 61
2024
Q3
$1.75M Buy
5,438
+189
+4% +$61.8K 0.48% 48
2024
Q2
$1.64M Sell
5,249
-22,251
-81% -$6.54M 0.51% 40
2024
Q1
$7.82M Buy
+27,500
New +$8.05M 3.14% 10

Other funds holding AMGN

Thurston Springer Miller Herd & Titak's AMGN Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Amgen (AMGN) stake by 15% in Q2 2026, buying an estimated $136K and bringing the position to 3,012 shares worth $1.09M. The position accounts for 0.4% of the portfolio, ranked #65.

Thurston Springer Miller Herd & Titak first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $7.82M in Q1 2024. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 3,012 shares of Amgen worth $1.09M as of Q2 2026.
  • Thurston Springer Miller Herd & Titak bought 396 Amgen shares in Q2 2026, an estimated $136K.
  • Amgen made up 0.4% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #65 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • Thurston Springer Miller Herd & Titak's Amgen position peaked at $7.82M in Q1 2024.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.